Art

J-GLOBAL ID：200902267683078865   Reference number：07A0132706

In Vitro Antifungal Activities of Sulfa Drugs against Clinical Isolates of Aspergillus and Cryptococcus Species

Aspergillus属とCryptococcus属の臨床分離菌に対するサルファ剤のin vitro抗真菌活性

Author (5)： HANAFY Ahmed (Chiba Univ., Chiba, JPN) ,  UNO Jun (Chiba Univ., Chiba, JPN) ,  MITANI Hiroki (Chiba Univ., Chiba, JPN) ,  KANG Yingqian (Chiba Univ., Chiba, JPN) ,  MIKAMI Yuzuru (Chiba Univ., Chiba, JPN)
Material： 日本医真菌学会雑誌  (Japanese Journal of Medical Mycology)
Volume： 48  Issue： 1  Page： 47-50  Publication year： Jan. 31, 2007 
JST Material Number： G0589A  ISSN： 0916-4804  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *antifungal action ,...
Semi thesaurus term： MIC(concentration) ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0132706&from=J-GLOBAL&jstjournalNo=G0589A") }}

JST classification (2)： Basic research of antifungal drugs  (GW17060K) ,  Physiology and pathogenicity of microbial infection  (EG03053T)

Substance index (1)： Sulfaphenazole

Reference (17)：

• 1) Myskowski PL, White MH, Ahkami R: Fungal disease in the immunocompromised host. Dermatol Clin 15: 295-305, 1997.
• 2) Van Burik JA, Magee PT: Aspect of fungal pathogenesis in humans. Annu Rev Microbiol 55: 743-772, 2001.
• 3) Latge JP, Calderone R: Host-microbe interactions: fungi. Invasive human fungal opportunistic infections. Opin Microbiol 5: 355-358, 2002.
• 4) Kwon-Chung KJ, Bennett JE: Cryptococcosis, In Medical Mycology pp.397-446., Lea & Febiger, Philadelphia, PA, 1992.
• 5) Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S: Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 10: 72-78, 2006.

Terms in the title (5)： Aspergillus属 ,  Cryptococcus属 ,  臨床分離菌 ,  サルファ剤 ,  抗真菌活性